![](https://investorshub.advfn.com/uicon/189332.png?cb=1465554763)
Friday, February 21, 2020 11:27:43 AM
If one was willing to rely on the consistency of the failure of those things over the last X number of years, however foolhardy that might be, they wouldn't find it hard to predict those things at all.
We know - for example - that the amount of a potential flu-cide that they would have needed to be able to produce to do Toxicity testing was far beyond their capabilities prior to the last year or so. I may - in fact - be beyond their capability now.
And as a Coronavirus-cide would almost certainly have to be ingested or injected, rather than a topical treatment like the Shingles-cide - in order to get a reasonable toxicity testing experiment done they would have to be able to produce the candidate drug in a similarly large quantity to Flucide, It is a huge "IF" that they could do even that.
And that is after 'assuming' that the AEC2 mimic ligand actually works and doesn't need to be tweaked or redesigned,...
Whether NNVC makes it or not - that's going to depend on the Shingles treatments. Unless somebody with really deep pockets and an agenda can push it forward - there's not much chance that a coronavirus-cide is going to come out before either this epidemic gets out of control, or burns itself out.
“The two most powerful warriors are patience and time.”
- Leo Nikolaevich Tolstoy
Recent NNVC News
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
- Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical Needs • InvestorsHub NewsWire • 07/06/2023 03:16:37 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM